News &amp; Updates

Saffron supplements show promise in managing ulcerative colitis (UC), with notable effects on inflammatory markers and clinical manifestations of the disease, as reported in a small study.

Saffron serves up benefits for patients with ulcerative colitis

PCOS tied to increased suicide attempts

Individuals with polycystic ovary syndrome (PCOS) appear to be at greater risk for suicide attempts, suggests a study, which notes the importance of routine monitoring of mental health and suicide risk in individuals diagnosed with PCOS.

PCOS tied to increased suicide attempts

16 Feb 2024

Revised obstetric VTE prophylaxis protocol prevents wound hematomas

Adopting a more conservative approach to venous thromboembolism (VTE) prophylaxis results in reduced rates of wound hematomas, with no increase in postpartum VTE, according to a recent study presented at SMFM 2024.

Revised obstetric VTE prophylaxis protocol prevents wound hematomas

16 Feb 2024

Alerting reaction during BP reading tied to CVD death

An alerting reaction during the first blood pressure (BP) reading is associated with a higher risk of cardiovascular disease (CVD) mortality among adults, reveals a study.

Alerting reaction during BP reading tied to CVD death

16 Feb 2024

SKYSCRAPER-08 hits mark in ESCC with dual checkpoint inhibition + doublet chemo

In Asian patients with esophageal squamous cell carcinoma (ESCC), adding the TIGIT inhibitor tiragolumab and PD-L1 inhibitor atezolizumab to chemotherapy improved all outcomes in the phase III SKYSCRAPER-08 trial.

SKYSCRAPER-08 hits mark in ESCC with dual checkpoint inhibition + doublet chemo

Hypercholesterolemia linked to poor prognosis in primary biliary cholangitis

In patients with primary biliary cholangitis (PBC), elevated total cholesterol levels are associated with dysregulation of lipid metabolism and may lead to poor clinical outcomes, as shown in a study.

Hypercholesterolemia linked to poor prognosis in primary biliary cholangitis

Original New Drug Application Approvals by US FDA (01-15 February 2024)

New drug applications approved by US FDA as of 01-15 February 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (01-15 February 2024)

High levels of salt added to food up CKD risk

Frequently adding salt to food significantly increases the risk of chronic kidney disease (CKD) in the general population, according to a recent study.

High levels of salt added to food up CKD risk

Potassium-competitive acid blockers linked to gastric cancer risk after H pylori eradication

Exposure to potassium-competitive acid blockers (PCABs) may heighten the risk of developing gastric cancer after successful treatment for Helicobacter pylori infection, according to a study.

Potassium-competitive acid blockers linked to gastric cancer risk after H pylori eradication

Alcohol abstinence boosts overall survival in alcohol-associated cirrhosis

Abstinence from alcohol may dramatically increase survival rates for individuals with alcohol-related cirrhosis, as reported in a study.

Alcohol abstinence boosts overall survival in alcohol-associated cirrhosis